Skip to main content

Table 1 Description of subjects with/without psoriasis studied

From: Metabolic syndrome and its components in patients with psoriasis

Characteristics

Subjects with psoriasis

Subjects free from psoriasis

p-values

Mean ± SD

Mean ± SD

Median (minimal-maximal values)

Median (minimal-maximal values)

Sex (♂/♀)

55/47

55/47

ns

Age (years)

49.32 ± 13.47

48.71 ± 13.84

ns

BMI (kg/m2)

27.7 (18.9-41.79)

27.36 (18.24-40.5)

ns

History

   

 - DM

14/102 (13.72%)

4/102 (3.92%)

0.024

 - HT

27/102 (26.47%)

21/102 (20.58%)

ns

 - DLP

36/102 (35.29%)

28/102 (27.45%)

ns

 - CD

6/102 (5.9%)

4/102 (3.92%)

ns

Blood pressure(mmHg)

   

 - Systolic

130.75 (96-200)

124.5 (90-184)

0.006

 - Diastolic

80.67 ± 12.38

78.06 ± 10.72

ns

Waist circumference (cm)

  

ns

99 (75-122)

98 (67-130)

 

87 (63-120)

83 (63-116)

Active tobacco consumption

35/102 (34.31%)

23/102 (22.54%)

0.063

Dietary control

24/102 (23.52%)

15/102 (14.7%)

ns

Exercise

   

 - Low

16/102 (15.6%)

17/102 (16.6%)

ns

 - Moderate

47/102 (46%)

59/102 (55.8%)

 - High

35/102 (34.3%)

23/102 (22.5%)

Consumption of alcohol (≥3/day)

55/102 (53.9%)

67/102 (65.6%)

ns

Fasting glycaemia (mg/dL)

99.1 (68.5-232.5)

91.95 (68.5-151)

ns

Glycaemia 120 min (mg/dL)

93.7 (45.1-264.9)

95.5 (48.7-286)

ns

HOMA Index

2.66 (0.85-22.73)

2.28 (0.51-9.42)

<0.001

Total Cholesterol (mg/dL)

201.16 (116.5-286)

197.17 (127-301.5)

ns

HDL cholesterol (mg/dL)

50.04 ± 11.91

51.66 ± 13.74)

ns

LDL cholesterol (mg/dL)

124.56 ± 28.77

128.02 ± 29.34

ns

Triglycerides (mg/dL)

98.19 (27.13-787.5)

87 (28.9-540)

ns

  1. BMI: Body Mass Index. DM: Diabetes Mellitus. DLP: Dyslipidaemia. HT: Arterial Hypertension. CD: Coronary disease.